ReviewAnnals of medicine and surgery (2012)2025
Shaping sustainable paths for HIV/AIDS funding: a review and reminder.
Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Evolution of ART Medication Adherence Support and Monitoring Across IeDEA Sites: Results From Three Waves of Consortium-Wide Site Assessment Surveys, 2017, 2020 and 2023.Journal of the International AIDS Society · 2026Article
- Bridging systems and selves: a qualitative exploration of peer navigation as a developmentally tailored engagement strategy for adolescent HIV services.BMC health services research · 2026Article
- Health services and programmatic responses to improving adolescent HIV care in Lusaka, Zambia: A descriptive qualitative study.African journal of primary health care & family medicine · 2026Article
- The Potential Impact of Federal Funding Cuts on Access to Pre-Exposure Prophylaxis in Atlanta, Georgia: Geographic Modeling Study.JMIR public health and surveillance · 2026Article
- A qualitative exploration of psychosocial determinants influencing viral load suppression among adolescents living with HIV: Application of social action theory.Health SA = SA Gesondheid · 2026Article
- The successful scaling-up of antiretroviral therapy globally has many lessons for advancing universal health coverage: progress at risk.Globalization and health · 2025Article
- Transitioning a large-scale HIV/AIDS treatment program from an international partner to a local Nigerian implementing partner: a before-after early outcomes assessment study.BMC health services research · 2025Article
- Pharmacoeconomic perspectives on HIV: integrating data for long-term treatment and prevention.Frontiers in medicine · 2025Review
- A Socio-Ecological Perspective on Linkage to HIV Care in Bandung, Indonesia: A Qualitative Study to Explore Barriers and Facilitators.Journal of multidisciplinary healthcare · 2025Article
- Strengthening anal cancer prevention in Abuja, Nigeria: Identifying barriers and potential strategies to improve training.PLOS global public health · 2025Article
- Using country-level variables to discover country clusters beyond traditional health policy and performance metrics: An unsupervised machine learning approach for HIV healthcare delivery and financing.PLOS global public health · 2025Article
- The global response to HIV/AIDS in sub-Saharan Africa: achievements, challenges, and perspectives for the future.Frontiers in public health · 2025Review
- Don't Wait Till Tomorrow: How to Support Underrepresented Undergraduate HIV Researchers Today From the Voices of Emerging Leaders.Journal of the International Association of Providers of AIDS CareArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fight against human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) has made significant progress over the past decades, yet sustainable funding remains a critical challenge. Despite advances in medical treatments and prevention methods, the financial resources needed to combat the epidemic consistently face uncertainties and shortfalls. As of 2023, approximately 37.7 million people are living with HIV/AIDS globally, with 1.5 million new infections reported annually. Sub-Saharan Africa remains the hardest-hit region, accounting for 67% of the global HIV burden. This paper examines the current state of HIV/AIDS funding, identifying key gaps and challenges in maintaining adequate financial resources. It highlights the effects of funding fluctuations on treatment accessibility, prevention programs, and research, stressing the urgent need for diversified and innovative financing mechanisms. The paper offers actionable insights into sustainable funding strategies by analyzing successful models such as public-private partnerships and social impact bonds. This review aims to inform policymakers, stakeholders, and the global community about the financial barriers to HIV/AIDS management and advocate for coordinated efforts to secure stable funding pathways. Ensuring consistent financial support is vital to preserving hard-won progress, expanding access to care, and achieving the ultimate goal of an AIDS-free generation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.